Literature DB >> 16973715

Acute distal colitis impairs gastric emptying in rats via an extrinsic neuronal reflex pathway involving the pelvic nerve.

H U De Schepper1, J G De Man, L Van Nassauw, J-P Timmermans, A G Herman, P A Pelckmans, B Y De Winter.   

Abstract

BACKGROUND AND AIMS: Patients with inflammatory bowel disease often present with abnormal gut motility away from the inflammatory site. We studied remote motility disturbances and their pathophysiology in a rat model of colitis.
METHODS: Colitis was induced 72 h prior to experiments using trinitrobenzene sulphate (TNBS) instillation. Inflammation was verified using histology and myeloperoxidase (MPO) measurements. To assess gut motility, we determined gastric emptying, distal front and geometric centre (GC) of intestinal transit 30 min after intragastric administration of a semiliquid Evans blue solution. The effects of hexamethonium (20 mg/kg), capsaicin (125 mg/kg) and pelvic nerve section on colitis induced motility changes were evaluated. c-Fos expression was studied in the pelvic nerve dorsal root ganglion (DRG) S1.
RESULTS: Colitis reduced gastric emptying from 38.4 (3.6)% in controls to 22.7 (4.4)% in TNBS treated rats in the absence of local gastric inflammation. Colitis had no effect on the distal front or on the geometric centre of small intestinal transit. Hexamethonium reduced gastric emptying in controls to 26.3 (4.1)% but restored it to 35.8 (4.4)% in TNBS treated rats. Capsaicin significantly impaired gastric emptying in controls from 33.1 (5.2)% to 9.5 (3.3)% while this effect was less pronounced in TNBS treated rats (from 19.2 (2.3)% to 11.5 (3.8)%; NS). In TNBS treated rats, pelvic nerve section completely restored gastric emptying from 19.8 (5.3)% to 52.5 (6.3)% without any effect on gastric emptying in control rats. TNBS colitis induced de novo c-Fos expression in the DRG S1.
CONCLUSIONS: Experimental colitis in rats delays gastric emptying via a neuronal pathway involving pelvic afferent nerve hyperactivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973715      PMCID: PMC1856754          DOI: 10.1136/gut.2006.104745

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Effect of adrenergic and nitrergic blockade on experimental ileus in rats.

Authors:  B Y De Winter; G E Boeckxstaens; J G De Man; T G Moreels; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

2.  Characterization of mechanosensitive pelvic nerve afferent fibers innervating the colon of the rat.

Authors:  J N Sengupta; G F Gebhart
Journal:  J Neurophysiol       Date:  1994-06       Impact factor: 2.714

3.  The mechanism of altered neural function in a rat model of acute colitis.

Authors:  K Jacobson; K McHugh; S M Collins
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

Review 4.  The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders.

Authors:  S M Collins
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

5.  Participation of capsaicin-sensitive afferent neurons in gastric motor inhibition caused by laparotomy and intraperitoneal acid.

Authors:  P Holzer; I T Lippe; R Amann
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

6.  Effects of kappa opioids in the inflamed rat colon.

Authors:  J N Sengupta; A Snider; X Su; G F Gebhart
Journal:  Pain       Date:  1999-02       Impact factor: 6.961

7.  The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques.

Authors:  E Sabattini; K Bisgaard; S Ascani; S Poggi; M Piccioli; C Ceccarelli; F Pieri; G Fraternali-Orcioni; S A Pileri
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

8.  Characterization of suppression of food intake following acute colon inflammation in the rat.

Authors:  K McHugh; T W Castonguay; S M Collins; H P Weingarten
Journal:  Am J Physiol       Date:  1993-11

9.  Protective role of vagal afferents in experimentally-induced colitis in rats.

Authors:  L Mazelin; V Theodorou; J More; J Fioramonti; L Bueno
Journal:  J Auton Nerv Syst       Date:  1998-08-27

10.  Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed.

Authors:  V Annese; G Bassotti; G Napolitano; V Frusciante; M Bruno; P Conoscitore; U Germani; A Morelli; A Andriulli
Journal:  J Clin Gastroenterol       Date:  1995-12       Impact factor: 3.062

View more
  13 in total

1.  Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice.

Authors:  Nathalie E Ruyssers; Benedicte Y De Winter; Joris G De Man; Natacha D Ruyssers; Ann J Van Gils; Alex Loukas; Mark S Pearson; Joel V Weinstock; Paul A Pelckmans; Tom G Moreels
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

2.  Enhancing Atorvastatin In Vivo Oral Bioavailability in the Presence of Inflammatory Bowel Disease and Irritable Bowel Syndrome Using Supercritical Fluid Technology Guided by wbPBPK Modeling in Rat and Human.

Authors:  Mo'tasem M Alsmadi; Nour M Al-Daoud; Rana M Obaidat; Niazy A Abu-Farsakh
Journal:  AAPS PharmSciTech       Date:  2022-05-18       Impact factor: 3.246

3.  Colitis affects the smooth muscle and neural response to motilin in the rabbit antrum.

Authors:  Inge Depoortere; Theo Thijs; Sara Janssen; Betty De Smet; Jan Tack
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

4.  L-Glutamine and Physical Exercise Prevent Intestinal Inflammation and Oxidative Stress Without Improving Gastric Dysmotility in Rats with Ulcerative Colitis.

Authors:  Raisa de Oliveira Santos; Geovane da Silva Cardoso; Lara da Costa Lima; Mickael Laudrup de Sousa Cavalcante; Mariana Sousa Silva; Ana Karolina Martins Cavalcante; Juliana Soares Severo; Francisca Beatriz de Melo Sousa; Gabriella Pacheco; Even Herlany Pereira Alves; Lívia Maria Soares Nobre; Jand Venes Rolim Medeiros; Roberto Cesar Lima-Junior; Armênio Aguiar Dos Santos; Moisés Tolentino
Journal:  Inflammation       Date:  2020-10-31       Impact factor: 4.092

5.  Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation.

Authors:  Louise Pontell; Patricia Castelucci; Mária Bagyánszki; Tanja Jovic; Michelle Thacker; Kulmira Nurgali; Romke Bron; John B Furness
Journal:  Virchows Arch       Date:  2009-06-11       Impact factor: 4.064

Review 6.  Neuroanatomy of lower gastrointestinal pain disorders.

Authors:  Wim Vermeulen; Joris G De Man; Paul A Pelckmans; Benedicte Y De Winter
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 7.  Plasticity of enteric nerve functions in the inflamed and postinflamed gut.

Authors:  G M Mawe; D S Strong; K A Sharkey
Journal:  Neurogastroenterol Motil       Date:  2009-03-11       Impact factor: 3.598

8.  TRPV1 receptors on unmyelinated C-fibres mediate colitis-induced sensitization of pelvic afferent nerve fibres in rats.

Authors:  H U De Schepper; B Y De Winter; L Van Nassauw; J-P Timmermans; A G Herman; P A Pelckmans; J G De Man
Journal:  J Physiol       Date:  2008-08-28       Impact factor: 5.182

9.  NMDA receptor subunit expression and PAR2 receptor activation in colospinal afferent neurons (CANs) during inflammation induced visceral hypersensitivity.

Authors:  Shelby K Suckow; Robert M Caudle
Journal:  Mol Pain       Date:  2009-09-22       Impact factor: 3.395

10.  Dyspeptic symptoms and delayed gastric emptying of solids in patients with inactive Crohn's disease.

Authors:  Ana Carolina Mello Nóbrega; Bruno Roberto Silva Ferreira; Graciela Josué Oliveira; Kamila Maria Oliveira Sales; Armênio Aguiar Santos; Miguel Ângelo Nobre E Souza; Lúcia Libanês Bessa Campelo Braga; Luiz Ernesto de Almeida Troncon; Marcellus Henrique Loiola Ponte Souza
Journal:  BMC Gastroenterol       Date:  2012-12-07       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.